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A computer sc~tr~h revealt'd I 0 proteins with homology to the sequence v~. orilm~lly idtntttlcd in vtmcntln ~ts the sate ofcleaville by human immune. 
denciency vlrus tyl~ I (HIV.I} protctt~ Or th~se I0 proteins (aetln. t .ctmln, $~¢trln. trolsOmyollns, vlnculln, dystrophln, MAP.2, vdlln. "rRK.I 
tt.td It p.ch~tin), ~¢ lhow that 4 of th~ i~rst S v~re cl~v~d m vitro by thi~ prole~<, ~t~ ~trc MAP.I  and .2 [(1990) J Gin Virol ?I, l'mS=1991}, 
in these proteins, cl,Ivtti© is not re4tr~eted to tt tmlll© motif, but oo~urs at many sites However. cleavage is not random, smc~ 9 other pros=ins 
in¢ludlng the eytoskel~tnl prot¢m.t, f.lamin und bind 4 1 art not cleaved .n the tn vitro assay. Thus, the ability ofHlV.l protca~ to cl¢.~tv~ spt'cdlc 
components or th© cylosk¢leton m~y b¢ an tmportint, tdthoulh t~s )el unevaluAted as~ct of the life cyc], of thts retrovlrus and/or may dJr~tly 
contrtbuttt to the l~ttho|tn~ts ob~rved durmlI mf~tion, 
HIV. l pretense, Cytosk,letal protein, lnttnttton factor 2 (IF 2) 
I, INTRODUCTION 
Retrovirally encoded pretenses are aspartyl proteases 
responsible and required for the cleavage of viral 
precursor polyproteins into the functional proteins of 
the mature vtrus particle (revtewed in ref l and 2). This 
processmg is required for viral infectivity and no host 
pretenses have been identified that can substttut¢ for 
this enzyme. Smce no specific cleavage of host cell pro- 
terns has been directly demonstrated m retrovtrus in. 
fected cells, tt has generally been accepted that the 
retrov~ral proteases are specific for viral proteins. We 
have recently shown that purified HIV.I pretense can 
cleave intermediate ftlament proteins tn v~tro and have 
tdenttfted the primary cleavage s~te of vtmentm to be 
SLNL/RE [3]. This site resembles a hybrid between two 
classes of viral protem cleavage sites [4], with the nov:l 
presence of an R at the stssile bond, Since zt was also 
observed that mtcromj¢cted HIV-I pretense not only 
alters vimentin intermediate filament distribution in 
human fibroblasts, but also causes changes in cell shape 
[3], we have searched for other cytoskeletal components 
that can be cleaved by th~s enzyme. In the present study, 
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candidate proteins were identifted by computer search 
using consensus sequences of known cleavage sites. We 
report here that 4 cytoskeleta[ proteins can be spect- 
fically cleaved by HIV-I protease in vitro and predtct 
that additional proteins may also be substrates. 
Cleavage of one of these predtcted substrate proteins, 
MAP-2, has been mdependently reported by Wallin et 
.d, [Sl. 
2. MATERIALS AND METHODS 
The SWISSPROT data base of the EMBL data bank (European 
Molecular Biology Laboratory, Heidelberg, Germany) was searched 
using the FASTSCAN program for those proteins with the best 
homology to the vlmentm primary cleavage site SLNLRE [3] A 
smular search of this data base was made for cytosk¢letal proteins us- 
mS the various cleavage sites tabulated by Kay and Dunn [2] for 
retrovtral pretenses 
Human cytoplasmic actm from HeLa cells was punf, ed through 2 
rounds of polymerIzatlon/depolymenzatlon according to standard 
protocols [6,7] 14uman vlmentm was prepared from HeLa cells [3] 
Total erythrocyte ghost prote,ns and spectrm (o¢- and ~'-forms) were 
~solated [8] from normal human erythrocytes obtained from a 
volunteered donation at a local blood bank The remaining substrate 
proteins were obtained from commercial sources bovine and ch,cken 
tropomyosms, chicken a,-actmm, and chicken fflamm were from 
Szgma (Detsenhofen, Germany) and chicken vmcuhn was from 
Amersham-Buchler (Braunschwetg. Germany) HIV-I protease (more 
than 90% pure) was kindly provzded by S Roy (Hoffmann.La Roche, 
Nutley, N J, USA) Protein standards for Me determmat,on (LMW 
cahbrat~on kit) were purchased from Pharmacla-LKB (FreLburg, Ger- 
many) Bio.Rad SDS-PAGE standards, low range (Cat No 
161-0304, Bto-Rad, Mumch, Germany) were employed as a source of 
nauve proteins for control reactions (see below) Th~s preparation 
consists of a mixture of rabbit muscle phosphorylase B (MW 97 400), 
bowne serum albumin (MW 66200), hen egg white ovalbumm (MW 
4S 000). bovine carbonic anhydrase (MW 31 00O), soybean trypsin In- 
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hlbilor (MW 21 ~Og) and hen ellll wh|l~ ly'm,ym¢ ('vtW 14400}, each 
at u ,,on¢¢ntt~ti~n or - = mll,,'rnl ht ~II~'. llycerol. }00 mM Noel, 3 
I~M NaNt lind I(30 mM DrT. rltl, s~lullOe was diluted I' 20 with the' 
itAnd~Ird buffer for thl  In ~ltro IIIV'.I prts,¢w~ ~ls~y Oct ~low) 
Rem¢tion ¢ond)tlo,~ and ~DS.PAGE *ere ~s dewrlbcd [;~l. In br)er, 
10,sll of  the indlvldu,~l pro, eros were in,:libl~led at 3'i"C for :SO rain in 
,he prewnce of 20 pmol (for vlmentln) or 40 pm¢l tall oth(r pip,lint) 
or HIV.I pro,ease in a final volume of lOOa, l ¢Onlamlnll 20 m&l 
sodium phosphate, pi| 6 $, $ rnM LGTA, I0 mM DTT, I mM 
phen!, )melhyls,llfon)l f uoride, L'onwul reu¢tmns were performed by 
nddl~ll pepstatm A, ~n inhibitor or aspar,yl proteaw,L 12 I, to the reac, 
non ,nlxturcs at a final con¢~mra[ion or o,'/mM from a 20 mM sto~;k 
,solution prepared in dlmethyl ~ulfo~id¢. Equal ahquolt or reaction 
mixture- were apphed |o 9-1gee aerylarnlde seh ¢tnd proteins v~er¢ 
~, ~suali,ed b)' stmmnll with Coorn~ssl¢ blue 
3. RESULTS AND DISCUSSION 
Ten eukaryotic proteins were identified by a com. 
puter search for homology to the vimentin cleavage se. 
queace SLNLRE (Table l), When these I0 proteins and 
other cytoskeletal proteins such a~ actin, tubulin, and 
erythrocyte band 4,1 proteins were additionally search- 
ed for homology to the known viral protein cleavage 
site [2], only actin was found to possess significant 
homology to these sequences (Table 1). Gwen the 
relatively low absolute sequence requirements of HIV-1 
protease [1-4], these less-than-perfect matches (Table I) 
are of questionable s~gnlflCanCe Nonetheless, we chose 
to test a number of these potenual substrat¢s and con- 
trol proteins in an in vitro assay for HIV-I protease. Of 
the 5 predtcted substrate proteins tested, 4 were found 
to be cleaved by HIV.I protease in vitro: actin, a- 
actinin, u- and B-spectrin and tropomyosins (both 
ehicker~ (Flit. I) and bovine (data not shown)). Chicken 
vinculln wa~ not cleaved in our assay (Fig. l) even 
thouilh it was a candidate based on the computer 
search The other cytoskeletal proteins tesled, ¢rythro- 
cyte band 4.1 proteins and filamin, were not identified 
as candidate substrat¢= by the computer ~earch and thus 
served as controls; indeed these proteins wer~ not cleav- 
ed (Fill. I and data not shown). Furthermore, addi- 
tional proteins tested, phosphorylase B, ovalbumin, 
carbonic anhydrase, soybean trypsin inhibitor, lyso- 
zym¢ (all in Fig. 1) and tubulin [5] were not clea~,ed by 
HIV-! proteas© in vitro. The partial cleavage of bovine 
serum albumin observed (Fig, IB) indicates that thls 
protege1, although el¢ctrophoretically pure, was part,al- 
ly denatured. We have previously shown that bovine 
serum albumm is cleaved by HIV-! pretense only when 
denatured [3] and have since observed that this is a sen- 
stove assay of the quahty of a bovine serum albumm 
preparation (data not shown), The cleavage of vimen. 
tin, actm, ct-actinin, r~. and #-spectrins and the various 
tropomyosins was dependent on the added HI.V-I pro- 
tease (Fig. I) and could be inhibited by the aspartyl pro- 
tease inhib=tor pepstatin A (data not shown). The 
likehhood of contamtnatmg pretenses contributing to 
the observed effect was reduced by routinely carrying 
out the reactions in the presence of EGTA and phenyl- 
methylsulfonyl fluoride; however, no effect was noted 
in the presence or absence of these reagents, 
The change tn Mr of these proteins ts in good agree- 
ment w,th at least one of the indicated sites in Table I 
for o-act,nin as well as the tropomyosms and acttn 
Table [ 
Actual and predicted HIV.I protease cleavage sLtes in mamn~ahan cell proteins (see section 2) The 
v~mentm cleavage site determmeO by m,crosequcncmg =s pnnted bold, the predicted cleavage s)tes 
are in norn~al letters and Iov, er case levers are used to indicate tier)orlon from combmahons  or 
the consensus equences The positions of the first am=no acids (P4) of these sites ,,,,ere obtained 
f rom the data bank entries A "+"  m the cleavage column indicates detectable cleavage by HIV-I 
protease of the purified protein in an m vii ro assay (see F~g I ) and a secor~d "+"  )ndicat¢s 8odd 
ag, eement o f  the M, of the observed and predtcted cleavage product(s) NT, not tested 
Protein Actual and predicted Position Cleaved 
cleavage s~tes (hrst aa) 
P4 P3 P2 Pl  P l  ' P2 
Vtmennn [24] S L N L R E 418 + + 
Tropomyosm [25} S L N r R i 30,51,8"/ ÷ + 
Vtnculm [26] S 8 N k R a 94l - 
~-Actmm [27] S v N a R c 471 + 
i Q N F h , 166 + + 
ar-Spectrm [28] k f y L F L 1352 + 
S Q e L a E 1376 + 
A R d L A s 1697 + 
Actin [29] T L k Y P l 66 + + 
1 R V a P E 94 . + 
t F N t P a 126 + + 
Dystrophln [16] S L N L R v, 2187 NT 
t R N Y P q 148 NT 
Ig, ~-chaln [30] S L N L R s 81 NT 
MAP-2 [31] S 1 N L P m 78 NT 
TRK- I  [32] S L N r R 1 51 NT 
Vdhn [33] S G N L R d 732 NT 
zOO 
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Frog I, SDS.PAGE analysis of m vitro mc.ubatlon assays for cleavage of varmus preteens by HIV- I prot©ase. Reacuon condillons and SDS.PAGE 
wereas described [3] The Indlcatccl proteins were incubated ,n the absence (odd numbered lanes) or presence (even numbered lanes) of HIV.I pro. 
tease (see s¢ciion 2) For panel A, samples were applied as foqows hur~an vlmenun, lanes I and 2, human actm, lanes 3 and 4, chncken 
tropom~osms, lanes S and 6. chicken cr aetmm, lanes '7 and 8; human spectrin (u. and,d-), lanes 9 and lO, chicken fdamin, lanes l I and 12, clucken 
vmcuhn, lanes 13 and 14; and protein slandards, lanes M The cleavage products of the respective proteins are rod=cared by arrows and an atria 
conh~m)nan[ of the u.nctmm and spectnn preparations is md~cated by a dot, note that it=as actm is also readily cleaved The protein standards 
(Pharmacna-LKB, LM W k=t) have ~,  values (from top Lo bottom) o t 94 ~,  68 ~,  43 ~,  30 ~0,  20~ and 14 ~ Vlmentm and actm are clear- 
ed almost equally well under tlies¢ conditions, |lie turnover number for the other pro[eros are lower by factors 10-1~ For panel B, the proteins 
=n ¢he B~o.Rad standard (see section 2) (a glycerol susl)ension of, from top to bottom, rabbet phosphorylase B, bovine serum albumin, chicken 
ovalbumm, bovine carbonic antlydrase, soybean trypsin inhJb=tor and ch=cken lysozyme) were incubated under standard conditions m the absence 
(lane 15) or presence (lane 16) of HlV-I pretense, The partml cleavage of bovine serum albam=n =s return=scent of the cleavage of heat-denatured 
bovine serum albumin [3] The HIV-I pretense monolner has a Mr - I l 000 m~d g=ves rise to lhe two bands w=th the lowest Mr seen in lane 16 
(which are multiply cleaved), but not for the h~ghest Mr 
pepfides derived from the spectrms, even though they 
are clearly cleaved. The tropomyosins are a family of 
closely related cytoskeletal protelns possessing amino 
acid sequences hlghly conserved not only among the 
various cellular isoforms, but also between species. The 
sequence presented m Table I ns found in all of the 
various tropomyosins listed in the SWISSPROT data 
bank, hence the muluple listings for sequence locauon 
(Table I). The HIV-I proteas¢, hke other retrovlral pro- 
teases [9], can cleave heat-denatured, but no natlve 
BSA, making It doubly necessary to exercise caution in 
the interpretatmn of the relevance of the cleavages 
demonstrated in Fig. 1. We believe our actin and spec- 
trm preparauons to be m a native state since these pro- 
teins were isolated without he use of denaturing agents 
and these proteins retained the abihty to form typical 
microhlaments and to bind actin, respectively (data not 
shown). Addmonally, c~- and B-spectrm were the only 
proteins m an erythrocyte ghost preparation that were 
detectably cleaved, supporting the notion that this 
cleavage ~s specfflc and  not due to wholesale protein 
denaturation. A l though we have no data on  the state of 
the commercial ly  obtained tropomyosins, it is known 
that thls family of proteins xs extremely robust and 
resistant to denaturation; indeed, these properties are 
used to isolate and purify these proteins [10]. 
A criticism of the present study is the lack of 
demonstrated correlation between the results presented 
m Table I and F~g. 1. Corroboration of the original 
hypothesis, that the potential sites identlfied by 
homology comparisons are actually utflxzed by HIV-I 
protease, reqmres that the sequence of all the cleavages 
observed in Fig. l be determined by peptide sequen- 
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crag. While this hi a desirable approach, it was neither 
our original intention nor ultimate goal; rather, we 
chose to u~e the predictions presented in Table l as 1he 
basis for a rational selection of proteins to test in our in 
vitro assay. In this respect, it is notable that 4 of the S 
candidates tested were cleaved and the several control 
proteins were not cleaved. Although it remains to be 
demonstrated exactly wh=ch sequences and what addl- 
lionel target structure requirements HIV-I protease 
possesses, it is quite obvious that there are, m contrast 
to current dogma, a broad spectrum of' host cell pro- 
teins sensitive to cleavase by HIV-I ~rotease, at least in 
vitro, This result, in our opinion, is the major finding of 
this study and has wide.ranging implicat,ons for the 
study of retrovlrus-host cell interactions. 
During our original experiments [3], we were not able 
to precisely locate the primary cleavage site of porcine 
desmin (since only a partial protein sequence was 
available [i 1]); however, it was quite clear, based on the 
M, values of the cleavage products, that the desmin se- 
quence (ALNFRE) homologous to the vimentin 
primary cleavage site (SLNLRE) was not efficiently 
cleaved [3]. This suggests that for this type of cleavage 
site the S at the P4 position plays a more critica[ role 
than a preferred amino acid (F) at th, Pl position [12], 
Since the vimentin primary cleavage site resembles a
hybrid of known viral consensus sequences surrounding 
the sisstle bond, ,t =s not unreasonable to predict that 
other s~mdar hybrids of the known types of cleavage 
sites [1,2,4] may also be recognized by the enzyme 
While the presence of g at the P' position of the v~men- 
tin primary cleavage site was originally surprising [3], 
the pred~cuon of an R-R dtpeptide as the sissile bond 
for tropomyosins (Table I) borders on the heretical. In 
systematic studies on peptide substrates of HIV-I pro- 
tease, Konvalinka ctal. [12] found that no hydrolysis 
was observed when an R or E was present at position 
P 1; however, their model pepttdes had sequences differ- 
ing in additional positions from that of the v~mentm 
primary cleavage site or those others proposed in Table 
I. In this respect, ~t is important o note that the active 
form of the HIV. 1 pretense isa mirror ~mage dimer and 
that nonpeptide, symmemcal compounds can functmn 
as inhibitors of this enzyme [13]. It is thus conceivable 
that if one R can be well-tolerated within the active site, 
an R-R dipeptide may also (since ~t, too, presents a 
symmetrical conformation). Konvahnka et el. [12] also 
note that the ability of the substrata peptide to adopt an 
appropriate configuration within the active site ~s an 
important d¢terminar~t for cleavage. It is thus con- 
ceivable that the conhgurat~on of the sites cleaved by 
HIV-I protease in the various proteins (Fig. 1) may 
likewise play an ~mportant role in their utihzauon, as 
has been demonstrated for v~mentm in aatwe and heat- 
denatured forms [3]. A study by Margolin et al. [14] 
suggests that preferred residues at position P2' should 
possess medium-sized hydrophobic side chains (i.e. I or 
L, but no| W or F): for that cast where a charj~cd 
residue (E} is found, they suj|est tiler the local mtcrotn- 
vironment plays a crucial role in determining cleav~bili. 
ty (m this case, by keepinll the E residue pro|onated), 
From this brief discu~slon, it is clear that a multitude or 
factors are involvcd and may positively or neilatively in- 
fluence a specific sequence/structure's cleavage by 
HIV-I pretense, 
In addition to the proteins listed in Table I, a poten- 
tial cleavage site (SLDLRY) ~as Identified m Esche- 
richla co/i smtiation factor 2 (IF2). This is of signifi. 
canto in the light of observations that in recombinant 
bacteria the expression of active H[V-I  prot~al¢ ap- 
pear,; to be toxic and inhibits cell growth. This property 
has even been exploited to positively select for muta. 
tions in cloned HIV-I pretense genes [lS]. It will be of 
interest to see if iF2 really is a substrata for HIV.I pro- 
tease; if so, the yield of HIV.I pretense might be ,n-  
proved in strains possessing other isof'orms of IF2 or, 
alternatively, overexpressing IF2 from a compatible 
plasmid to compensate for turnover. 
Since our initial observations [3] that micromjected 
HIV-I pretense not only alters vimentm intermediate 
filament distribution in human fibroblasts, but also 
causes changes in cell shape [3], we have searched for 
other cytoskeletal components that can be cleaved by 
this enzyme. We report here that 4 additional proteins 
can be specifically cleaved by HIV-I protease in vitro 
and predict that additional cytoskeletal proteins may 
also be substrates (Table I). Of these, dystrophin, an 
important muscle cell cytoskeletal protein modlhed or 
absent in muscular dystrophy [16], is of special interest 
m light of the unexplained myopathy often observed in 
many HIV-I infected individuals [17]. Of course, 
cleavage of other cytoskeletal proteins, such as actm, 
may equally hkely play a role in this, although if actin 
~s involved it must be m a cytoskeletal form rather than 
part of an actin-myosm complex to fit w~th the 
pathological findings. After completion of this manu- 
script, Walhn et al. [51 reported that I-IIV-I protease 
cleaves both MAP-I and MAP-2, a finding consistent 
with our hypothesis (Table I). 
Given the conservation of structure and slmilanties 
of cleavage sites among retrovlral proteases [I,2], we 
would predict that other retroviral proteases probably 
also cleave host cell proteins; indeed, these are reports 
[18] of alterations in cell shape in Rous sarcoma virus 
(RSV) infected cells that could easily be accounted for 
if the RSV protease has similar properties. Wallin et al. 
[5] have shown that the protease encoded by both 
HIV-I and AMV (avian myeloblastosis virus) can 
cleave MAP-I and MAP-2 m v~tro, thereby interfering 
with microtubule assembly. We have prevmusly noted 
[3] the cleavage of vimentin observed [19] in Moloney 
murine sarcoma v~rus infected cells ~s hkely due to the 
viral protease. The abihty to disrupt the host cell 
cytoskeleton, which among other funcuons anchors to 
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and st~bilixes the plasm~ membrane, may be an 
obligate requirement for an enveloped virus for botl~ 
entry into the cell and ~p¢¢i~lly for =an orderly budding 
from the cell surface during virus proliferation. 
Protease.def'e¢tive HIV. I  strains do not bud in a 
regular fashion [20,21]; these studies SUilite~| that such 
viruses bud aberrantly into intracellular vesicles and are 
released when these fuse with the plasma membrane, A 
murine retrovirus, A.2/C1.2.2, has been observed [22] 
co occasionally have long actln microfllaments attached 
to free viral particles, presumably as a consequence of 
the budding process. It has previously been proposed 
that actin microfilaments are actively involved in the 
budding process of  budding viruses [23]. Preliminary 
experiments (data not shown) indicate that, as witl~ 
vimentin (3], polymeric actin (F-actin) IS much more 
resistant itan actm monomers (G-actin) to cleavage by 
HIV-I protease in vitro. The significance of this obser- 
vation is not yet completely understood, but clearly sug- 
gests that cleavage of acttn, 1 f` 11 indeed takes place tn 
rive, must occur at specific structural loci rather than as 
random cleavage of all actin molecules. We propose 
that disturbance of the crossiinks of the cytoskeleton by 
cleavage of sens~tiva proteins (Table I and Fig. 1) by the 
retrovlral protease might be necessary before the bud, 
containmg the vLral precursor proteins, may be pushed 
out and released from the cell, 
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